Divalproex Sodium Tablet, Extended Release
Product Images NDC 70518-2036

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 70518-2036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Divalproex Sodium 500mg 70518 2036 01)

This is a description of a medication called Divalproex Sodium. The tablet is extended release and contains 500mg of the active ingredient. The medication is only available with a prescription and the label includes the NDC number, lot number, and expiration date. The tablets were manufactured in India by Amneal Pharma and repackaged by RemedyRepack Inc. The label advises to keep the medication out of reach of children and to store it at a temperature between 20-26°C (63-77°F). Instructions for use can be found in the package insert.*

FDA Label Image

Mm3 (Divalproex Sodium 500mg 70518 2036 02)

This is a prescription medication called Divalproex Sodium Extended-Release. The tablet contains 500mg of the drug and is in a bottle of 30 tablets. The lot number and expiration date are not readable. The medication is manufactured by Amneal Pharma in Ahmedabad, India. It is important to keep this medication out of reach of children. The package insert should be reviewed for directions on how to use the medication. It should be stored at a temperature between 20 to 26 degrees Celsius, but excursions to 15 to 30 degrees Celsius are permitted. This bottle was repackaged by RemedyRepack Inc. located in Indiana, USA.*

FDA Label Image

Remedy_label (Remedy Label)

This is a description of Divalproex Sodium Extended-Release 500 mg Tablets, a prescription medication manufactured by Amneal Pharma in Ahmedabad, India. The medication is packaged in bottles of 100 tablets, with the lot number and expiration date specified on the bottle. The medication should be stored at room temperature and kept out of reach of children. Directions for use can be found in the package insert. The tablets have been repackaged by RemedyRepack Inc. in Indiana, PA.*

FDA Label Image

10 (Divalproex Sodium Extended Release Tablets Usp 1)

FDA Label Image

Figure 1 (Divalproex Sodium Extended Release Tablets Usp 2)

FDA Label Image

Figure 2 (Divalproex Sodium Extended Release Tablets Usp 3)

The text appears to display a graph or chart that measures the reduction in CPS (unknown acronym) rate using low and high doses of Divalproex Sodium. The graph displays two bars for each dose, representing the percentage of patients who experienced improvement, no change, or worsening. The left bar represents the low dose while the right bar represents the high dose. The overall reduction in CPS rate is displayed as a percentage at the top of the chart.*

FDA Label Image

Figure 3 (Divalproex Sodium Extended Release Tablets Usp 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.